Research News

  • Ziegler Awarded BioTek Instruments’ Alpert Research Prize
    Winooski, Vt.-based BioTek Instruments announced August 31, 2016 that University of Vermont graduate student Christopher Ziegler is the recipient of the 2016 Norman R. Alpert Research Prize.

  • Solomon Study on Multiple Sclerosis Misdiagnosis Supports Improved Education of Clinicians
    A number of common conditions are mistaken for multiple sclerosis (MS), a disabling central nervous system disease, say researchers at four academic medical centers across the U.S in a study published online today in the journal Neurology.
  • May's Study Finds Connection between Chronic Pain and Anxiety Disorders
    New research provides insight into a long-observed, but little-understood connection between chronic pain and anxiety and offers a potential target for treatment. The study’s findings, published as an Article in Press in Biological Psychiatry, show that increased expression of PACAP – a peptide neurotransmitter the body releases in response to stress – is also increased in response to neuropathic pain and contributes to these symptoms.
  • Two College of Medicine Groups Awarded SPARK-VT Grants
    As the new academic year is set to begin, the innovative work of four University of Vermont research teams - including two groups from the College of Medicine - is moving closer to the marketplace in the wake of a Shark Tank-like competition called SPARK-VT held earlier this summer.
  • Spees’ New NIH Grant to Expand Study of Novel Post-Heart Attack Therapy
    A heart attack continues to harm cardiac muscle even after the immediate problem – a blocked artery – is fixed, but University of Vermont researchers have developed a new biologic drug that can preserve blood vessels critical to the body’s blood-pumping system.
  • Hehir Honored for Research and Clinical Commitment to Myasthenia Gravis Patients
    When University of Vermont neurologist Michael Hehir, M.D., treats patients with a relatively rare neuromuscular disorder called Myasthenia Gravis, he has to weigh the benefits of the medications he prescribes against their typical side effects.
  • UVM Clinical Trials Lead to First FDA Approved Cholera Vaccine in U.S.
    Cholera outbreaks continue to plague areas like South Sudan, Eastern Uganda, and Kerala, India, but there’s hope for addressing this infectious disease: Last month, the Food and Drug Administration approved the only vaccine for use in the U.S. to protect against cholera infection. The University of Vermont’s Vaccine Testing Center was one of three national sites to test the vaccine – called Vaxchora – for effectiveness.
  • Rincon Appointed Chair of NIH Cellular and Molecular Immunology Study Section
    The National Institutes of Health Center for Scientific Review has announced that internationally renowned immunobiologist Mercedes Rincon, Ph.D., University of Vermont professor of medicine, has been appointed chairperson of the Cellular and Molecular Immunology-A Study Section, Center for Scientific Review, the portal for National Institutes of Health (NIH) grant applications. She is serving a one-year term from July 1, 2016 through June 30, 2017.
  • Gramling's JAMA Oncology Study Addresses Doctor-Patient Miscommunication
    Clear communication between a doctor and patient is essential, especially when patients with advanced cancer wish to participate in decision-making about their medical treatment options, and trade-offs between quality and quantity of life emerge.
  • New Findings Highlight Potential Treatment Aim for Heart Mutation Underlying Sudden Death
    Two molecular physiologists at the University of Vermont (UVM) have taken a step closer toward a possible new treatment to address the underlying root cause of familial hypertrophic cardiomyopathy, an inherited disease that causes the heart muscle to thicken and struggle to pump blood.